ArticleThe British journal of dermatology2020

Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis.

S Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.